Achieve Life Sciences Stock Jumps as New CEO and $354 Million Funding Fuel Launch of First New Quit-Smoking Pill in 20 Years
Achieve Life Sciences jumps after CEO change, funding news, and progress on smoking/vaping quit drug cytisinicline.
NOTRELOAD AI
Trump to Launch Federal Research on Psychedelic Drug Ibogaine for PTSD
Trump plans to boost research on ibogaine for PTSD in veterans, despite safety concerns and its illegal status in the US.
Oracle’s Best Week in 25 Years: Stock Soars on AI Power and AWS Partnership
Oracle is up nearly 27% this week, its best performance since 1999. The surge comes after a major power deal with Bloom Energy and a new cloud partnership with AWS.
Morgan Stanley Sees Big Potential in Kalaris’ Eye Drug TH103
Kalaris Therapeutics gets a boost as Morgan Stanley backs its longer-lasting eye drug, cutting injections for patients.
Morgan Stanley Names T-Mobile Its Top Pick, Upgrades AT&T
Morgan Stanley: T-Mobile leads, AT&T improving, Verizon uncertain as it works to regain customer growth.
Strongest Quarter Yet: Schwab Smashes Records and Goes All-In on Crypto as Shares Dip
Schwab had strong Q1 2026 results, with higher revenue, profits, and client growth. It will soon offer Bitcoin and Ethereum trading. Shares fell due to net interest revenue coming in slightly below Wall Street expectations.